Discovery Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Discovery Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-234,715	Closed	-$9.2M	–	59
2018 Q2	$9.2M	Buy	234,715 +35,800	+18%	+$1.81M	0.5%	38
2018 Q1	$14.4M	Sell	198,915 -276,260	-58%	-$20.3M	0.5%	40
2017 Q4	$31.3M	Sell	475,175 -307,884	-39%	-$16.6M	0.97%	36
2017 Q3	$39.2M	Sell	783,059 -182,000	-19%	-$8.78M	0.94%	36
2017 Q2	$44.7M	Buy	965,059 +583,529	+153%	+$21.5M	1.08%	29
2017 Q1	$13.5M	Sell	381,530 -660,516	-63%	-$15.1M	0.25%	74
2016 Q4	$13M	Sell	1,042,046 -7,954	-0.8%	-$94.7K	0.22%	77
2016 Q3	$14.5M	Hold	1,050,000	–	–	0.31%	57
2016 Q2	$10.4M	Buy	1,050,000 +243,895	+30%	+$4.04M	0.24%	61
2016 Q1	$13.6M	Buy	806,105 +138,573	+21%	+$2.23M	0.2%	71
2015 Q4	$14.9M	Buy	667,532 +143,332	+27%	+$3.62M	0.18%	77
2015 Q3	$12.4M	Buy	+524,200	New	+$32.9M	0.14%	88

Other funds holding ESPR

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return